Cargando…

Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs

In China, progress to include the RV vaccine in the national immunization program (NIP) is slow. The only two vaccines, the Lanzhou lamb rotavirus vaccine (LLR) and Rotateq, are provided through the private market. This study aims to assess the health impact and cost-effectiveness of using three vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiahao, Zhang, Haijun, Zhang, Haonan, Fang, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Rotavirus – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019831/ https://www.ncbi.nlm.nih.gov/pubmed/35816415 http://dx.doi.org/10.1080/21645515.2022.2090162

Ejemplares similares

Cost-effectiveness analysis of introducing rotavirus vaccine into immunization program in Zhejiang province, China: A decision tree-Markov model study
por: Lv, Huakun, et al.
Publicado: (2023)

Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico
por: Gomez, Jorge, et al.
Publicado: (2023)

Parental preferences for rotavirus vaccination for their children under 5 years old in China: A discrete choice experiment
por: Ma, Wenwen, et al.
Publicado: (2023)

Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter
por: Wang, Xiaoqian, et al.
Publicado: (2023)

Impact of rotavirus vaccine introduction in Abidjan, Côte d’Ivoire
por: Britoh Mlan, Alice, et al.
Publicado: (2023)

Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms
por: Zhou, Yan, et al.
Publicado: (2023)

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial
por: Wu, Zhi-Wei, et al.
Publicado: (2023)

Established and new rotavirus vaccines: a comprehensive review for healthcare professionals
por: Vetter, Volker, et al.
Publicado: (2021)

Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges
por: Angel, Juana, et al.
Publicado: (2014)

Burden of rotavirus gastroenteritis on caregivers: Findings from a systematic literature review
por: Carias, Cristina, et al.
Publicado: (2022)

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2022)

Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013–2018)
por: Arístegui, Javier, et al.
Publicado: (2022)

Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era
por: Kozawa, Kei, et al.
Publicado: (2022)

Rotavirus and the web: analysis of online conversations in Italy during 2020
por: Marchetti, Federico, et al.
Publicado: (2021)

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule
por: Geard, Nicholas, et al.
Publicado: (2022)

Análisis exploratorio de datos sobre Gastroenteritis por Rotavirus en niños menores de 5 años en el Hospital General de Veracruz, S.S.A. 1995-2000
por: Martínez Cázares, Maria Teresa
Publicado: (2001)

National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis
por: Feng, Huangyufei, et al.
Publicado: (2022)

Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa
por: Sinanovic, Edina, et al.
Publicado: (2006)

Public–private partnership alternative for a national pharmacare program in Canada
por: Nauenberg, Eric, et al.
Publicado: (2023)

Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities
por: Zhang, Haijun, et al.
Publicado: (2023)

Changes in publicly and privately funded care in England following a national programme to reduce provision of low-value elective surgery
por: Anderson, Michael
Publicado: (2022)

The concept of marketing in the public-private partnership in the medical system in Romania
por: Purcărea, VL, et al.
Publicado: (2014)

Private Investments, Public Goods: Regulating Markets for Sustainable Development
por: Tan, Celine
Publicado: (2022)

The role of public-private partnerships in extending public healthcare provision to irregular migrants: stopgap or foot in the door?
por: Gottlieb, Nora, et al.
Publicado: (2020)

Post-marketing safety surveillance of the rotavirus vaccine in India
por: Kang, Gagandeep, et al.
Publicado: (2023)

An Analysis of Public-Private Partnerships and Sustainable Health Care Provision in the Kingdom of Saudi Arabia
por: Al-Hanawi, Mohammed Khaled, et al.
Publicado: (2019)

Moral Suasion and the Private Provision of Public Goods: Evidence from the COVID-19 Pandemic
por: Bos, Björn, et al.
Publicado: (2020)

Rotavirus vaccination is not associated with incident celiac disease or autoimmune thyroid disease in a national cohort of privately insured children
por: Kim, Catherine, et al.
Publicado: (2022)

Cost-effectiveness of a national enterovirus 71 vaccination program in China
por: Wang, Wenjun, et al.
Publicado: (2017)

Cost-effectiveness of Rotavirus vaccination in Vietnam
por: Kim, Sun-Young, et al.
Publicado: (2009)

Cost-effectiveness of rotavirus vaccination in Mozambique
por: Lourenço Guimarães, Esperança, et al.
Publicado: (2022)

Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina
por: Marti, Sebastian Garcia, et al.
Publicado: (2022)

Public–private collaboration in the provision of palliative care for children and adolescents with cancer: A Chilean experience
por: Fernández, Jazmine, et al.
Publicado: (2021)

Vaccination: Public and Private
Publicado: (1901)

Post‐marketing monitoring of intussusception after rotavirus vaccination in Japan
por: Bauchau, Vincent, et al.
Publicado: (2015)

Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted
por: Thomas, Sara L., et al.
Publicado: (2017)

National survey of smoking cessation provision in China
por: Lin, Haoxiang, et al.
Publicado: (2019)

Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
por: Pecenka, Clint, et al.
Publicado: (2018)

Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study
por: Lai, Xiaozhen, et al.
Publicado: (2021)

Coverage and Equity of Childhood Vaccines in China
por: Zhang, Haijun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c74jfafg3jqaretvbd7ddj8555